Balaxi Pharmaceuticals Ltd vs Titan Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 22.85 as of 12 Jun 15:30 . The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 13.8 on March 2021 to 14.1 on March 2025 . This represents a CAGR of 0.43% over 5 yearsThe P/E Ratio of Titan Biotech Ltd changed from 5.1 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 26.01% over 5 years The Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 524.5 crore on March 2021 to ₹ 352.89 crore on March 2025 . This represents a CAGR of -7.62% over 5 yearsThe Market Cap of Titan Biotech Ltd changed from ₹ 153.33 crore on March 2021 to ₹ 348.36 crore on March 2025 . This represents a CAGR of 17.84% over 5 years The revenue of Balaxi Pharmaceuticals Ltd for the Mar '26 is ₹ 73.63 crore as compare to the Dec '25 revenue of ₹ 72.64 crore. This represent the growth of 1.36% The revenue of Titan Biotech Ltd for the Mar '26 is ₹ 50.94 crore as compare to the Dec '25 revenue of ₹ 57.76 crore. This represent the decline of -11.81% The ebitda of Balaxi Pharmaceuticals Ltd for the Mar '26 is ₹ 3.04 crore as compare to the Dec '25 ebitda of ₹ 3.19 crore. This represent the decline of -4.7% The ebitda of Titan Biotech Ltd for the Mar '26 is ₹ 11.82 crore as compare to the Dec '25 ebitda of ₹ 12.09 crore. This represent the decline of -2.23% The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ 6.48 crore to ₹ 0.61 crore over 8 quarters. This represents a CAGR of -69.32% The net profit of Titan Biotech Ltd changed from ₹ 5.7 crore to ₹ 6.56 crore over 8 quarters. This represents a CAGR of 7.28% The Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Titan Biotech Ltd changed from 4.31 % on March 2021 to 9.04 % on March 2025 . This represents a CAGR of 15.97% over 5 years .

About Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Limited was initially incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017 and further changed to Balaxi Pharmaceuticals Limited in 2021.
Initially, the Company was incorporated with the object of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

About Titan Biotech Ltd

Titan Biotech Limited, the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms.
They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities. The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals sourced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

FAQs for the comparison of Balaxi Pharmaceuticals Ltd and Titan Biotech Ltd

Which company has a larger market capitalization, Balaxi Pharmaceuticals Ltd or Titan Biotech Ltd?

Market cap of Balaxi Pharmaceuticals Ltd is 126 Cr while Market cap of Titan Biotech Ltd is 1,837 Cr

What are the key factors driving the stock performance of Balaxi Pharmaceuticals Ltd and Titan Biotech Ltd?

The stock performance of Balaxi Pharmaceuticals Ltd and Titan Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Balaxi Pharmaceuticals Ltd and Titan Biotech Ltd?

As of June 14, 2026, the Balaxi Pharmaceuticals Ltd stock price is INR ₹22.85. On the other hand, Titan Biotech Ltd stock price is INR ₹444.75.

How do dividend payouts of Balaxi Pharmaceuticals Ltd and Titan Biotech Ltd compare?

To compare the dividend payouts of Balaxi Pharmaceuticals Ltd and Titan Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.